We showed that CSF ctDNA is more representative of brain tumour genomic alterations than plasma and putative actionable gene mutations and CNA (that is, EGFR, PTEN, ESR1, IDH1, ERBB2, FGFR2) can be identified. This evidence concerns the gene PTEN and brain neoplasm.